Nov. 17, 2011
/PRNewswire/ -- ProPhase Labs (NASDAQ: PRPH), makers of Cold-EEZE
, a leader in over-the-counter (OTC)
homeopathic cold remedies
, is excited to announce that Cold-EEZE has been awarded the Parent Tested Parent Approved (PTPA) Winner's Seal of Approval. PTPA Media has
's largest volunteer parent testing community, with over 40,000 parents. The seal of approval was awarded based on quality, effectiveness and value.
Cold-EEZE is the #1 pharmacist-recommended
zinc cold remedy
. Its proprietary zinc gluconate formula is clinically proven to safely and effectively reduce the duration and the severity of the
symptoms of a common cold
by nearly half (42%).
"This Seal of Approval reflects the high standards that we set for Cold-EEZE, and we are honored to receive this award," says
, Chairman and Chief Executive Officer of ProPhase Labs. "This recognition highlights the benefits and value that Cold-EEZE offers to families during the cough and cold season."
was among many entries from across
competing to earn the PTPA™ Seal. Independent parent volunteers evaluate these products in their own homes. Therefore, PTPA winners are chosen based on merit and consumer experience – not on commercial considerations. As a result, the PTPA Media™ Seal has quickly gained recognition as an international leader in certifying consumer products for quality, effectiveness and value. PTPA's CEO and founder,
, has appeared on over 40 morning shows as a reliable source for the latest and greatest in family products. The media and parents alike trust the collective opinion that PTPA Media represents.
"At PTPA Media, we are proud to play a role in certifying innovative products that families can trust," says Vinderine. "When consumers search for our Seal of Approval on product packaging and web sites, they are essentially searching for validation from their peers. Their peers will have objectively tested and approved these products based on their performance in a real life environment. That type of resource for families is priceless."